GlassScriptPhysician profile
William D Feltner
NPI 1497861777
$1,346.72
in general payments reported to CMS, 2019-2025
9 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $81.79 · 2021: $264 · 2022: $259 · 2023: $89.02 · 2024: $144 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $492.69 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $418.01 | 2020-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $215.38 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $93.10 | 2021-2023 | |
| Lilly USA, LLC | $40.71 | 2023-2024 | Jardiance, Emgality, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.36 | 2021 | |
| Allergan, INC. | $28.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.01 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Feltner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.